Literature DB >> 2954206

Monoclonal antibodies against murine neonatal and pregnancy-associated natural suppressor cells induce resorption of the fetus.

K O Grönvik, D W Hoskin, R A Murgita.   

Abstract

Pregnant and neonatal/fetal mice have been shown to harbour naturally occurring inhibitory cells of both T and non-T type. Non-T suppressor cells present in the spleen of primiparous pregnant and newborn animals inhibit proliferative responses in autologous and allogeneic mixed lymphocyte reactions. Such cells can be positively selected for by agglutination with the B cell-specific lectin soybean agglutinin (SBA). We generated rat IgG monoclonal antibodies against unique cell surface structures on the non-T inhibitory cells, and cytotoxic pretreatment of spleen cells from pregnant or neonatal/fetal mice largely abrogates their suppressive activity on proliferative responses. Furthermore, in vivo administration of such antibodies to pregnant inbred and outbred mice results in termination of the pregnancy or decreased litter size. Since injection of anti-T cell IgG monoclonal antibodies does not interfere with the delivery of normal sized litters it is evident from these studies that the non-T immunoregulatory cells, in contrast to T-inhibitory cells, are of great importance in ensuring immunological homeostasis in the fetal-placental environment during pregnancy in mice.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2954206     DOI: 10.1111/j.1365-3083.1987.tb02225.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  2 in total

1.  Specific maternal anti-fetal lymphoproliferative responses and their regulation by natural immunosuppressive factors.

Authors:  D W Hoskin; R A Murgita
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

2.  Isolation and characterization of a distinct immunoregulatory isoform of alpha-fetoprotein produced by the normal fetus.

Authors:  N S van Oers; B L Cohen; R A Murgita
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.